Literature DB >> 6446265

Antigenic competition as a therapeutic concept for alopecia areata.

R Happle.   

Abstract

Alopecia areata can be treated effectively by topical application of potent contact allergens. To explain the response, the following hypothesis is presented. Alopecia areata is considered an autoimmune disease. The characteristic peribulbar round cell infiltrates probably reflect a cell-mediated immune reaction to some hair-associated antigen. With the elicitation of contact allergy, a second antigen is introduced at the same site. The infiltrates of the allergic contact dermatitis contain suppressor T cells and suppressor macrophages which, in terms of local immunoregulation, exert a nonspecific inhibitory effect on the immune response against hair follicles. Regrowth of hair would be due to a change in the local balance between helper and suppressor cells. In conclusion, the phenomenon of antigenic competition is proposed as a therapeutic concept.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446265     DOI: 10.1007/bf00416931

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  36 in total

1.  Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

Authors:  T Tadakuma; C W Pierce
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  [Growing of hair in alopecia areata & maligna after intracutaneous hydrocortisone injection].

Authors:  K W KALKOFF; E MACHER
Journal:  Hautarzt       Date:  1958-10       Impact factor: 0.751

3.  Alopecia areata. Immunologic studies and treatment with prednisone.

Authors:  F Kern; W H Hoffman; G W Hambrick; R M Blizzard
Journal:  Arch Dermatol       Date:  1973-03

4.  Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells".

Authors:  P Phanupak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

Review 5.  The roles of T and B lymphocytes in self-tolerance and autoimmunity.

Authors:  A C Allison
Journal:  Contemp Top Immunobiol       Date:  1974

6.  Dinitrochlorobenzene: influence on the cytochrome P-450 system and mutagenic effects.

Authors:  J Kratka; G Goerz; W Vizethum; R Strobel
Journal:  Arch Dermatol Res       Date:  1979-11       Impact factor: 3.017

7.  [Pointer for DNCB therapy in alopecia areata].

Authors:  R Happle
Journal:  Hautarzt       Date:  1979-10       Impact factor: 0.751

Review 8.  Regulation of immune responses by suppressor T cells.

Authors:  C W Pierce; J A Kapp
Journal:  Tohoku J Exp Med       Date:  1976       Impact factor: 1.848

9.  Dinitrochlorobenzene therapy for alopecia areata.

Authors:  R Happle; K Cebulla; K Echternacht-Happle
Journal:  Arch Dermatol       Date:  1978-11

10.  Alopecia areata and Down syndrome.

Authors:  D M Carter; B V Jegasothy
Journal:  Arch Dermatol       Date:  1976-10
View more
  15 in total

Review 1.  Drug discovery for alopecia: gone today, hair tomorrow.

Authors:  Zenildo Santos; Pinar Avci; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2015-02-09       Impact factor: 6.098

2.  The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results.

Authors:  Jing Sun; Kathleen A Silva; Kevin J McElwee; Lloyd E King; John P Sundberg
Journal:  Exp Dermatol       Date:  2008-10       Impact factor: 3.960

3.  Cyclosporin-A-induced hair growth in human renal allograft recipients and alopecia areata.

Authors:  W Gebhart; J B Schmidt; M Schemper; J Spona; H Kopsa; J Zazgornik
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

4.  Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.

Authors:  R Happle; H M Klein; E Macher
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Suppressor cell decrease in alopecia areata.

Authors:  G N Ledesma; K K York
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

6.  Cell-mediated immunity in alopecia areata.

Authors:  R D'Ovidio; G A Vena; G Angelini
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

Review 7.  A review of monochromatic light devices for the treatment of alopecia areata.

Authors:  Evan Darwin; Harleen Arora; Penelope A Hirt; Tongyu Cao Wikramanayake; Joaquin J Jimenez
Journal:  Lasers Med Sci       Date:  2017-12-17       Impact factor: 3.161

8.  Does immunotherapy of viral warts provide beneficial effects when it is combined with conventional therapy?

Authors:  Jae Woo Choi; Soyun Cho; Jong Hee Lee
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

9.  Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.

Authors:  Solam Lee; Beom Jun Kim; Young Bin Lee; Won-Soo Lee
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

Review 10.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.